Literature DB >> 29967195

IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.

Kohsuke Shirakawa1, Jin Endo1, Masaharu Kataoka1, Yoshinori Katsumata1, Naohiro Yoshida1,2, Tsunehisa Yamamoto1, Sarasa Isobe1, Hidenori Moriyama1, Shinichi Goto1, Hiroki Kitakata1, Takahiro Hiraide1, Keiichi Fukuda1, Motoaki Sano1,3.   

Abstract

BACKGROUND: Both osteopontin (OPN) and galectin-3 have been implicated in phagocytic clearance of dead cells and reparative fibrosis during wound healing. CD206+ macrophages are involved in tissue repair through phagocytosis and fibrosis after myocardial infarction (MI). However, the relationship among OPN, galectin-3, and macrophage polarization in the context of MI remains unclear.
METHODS: The time course of Spp1 (encoding OPN) expression in the heart after MI showed a strong activation of Spp1 on day 3 after MI. To identify where in the body and in which cells the transcriptional activity of Spp1 increased after MI, we analyzed EGFP (enhanced green fluorescent protein)- Spp1 knockin reporter mice on day 3 after MI.
RESULTS: The transcriptional activity of Spp1 increased only in CD206+ macrophages in the infarct myocardium, and most of CD206+ macrophages have strong transcriptional activation of Spp1 after MI. The temporal expression pattern of Lgal3 (encoding galectin-3) in cardiac macrophages after MI was similar to that of Spp1, and OPN is almost exclusively produced by galectin-3hiCD206+ macrophages. Although both interleukin (IL)-4 and IL-10 were reported to promote CD206+ macrophage-mediated cardiac repair after MI, IL-10- but not IL-4-stimulated CD11b+Ly6G- cells could differentiate into OPN-producing galectin-3hiCD206+ macrophages and showed enhanced phagocytic ability. Inhibition of STAT3 tyrosine phosphorylation suppressed IL-10-induced expression of intracellular galectin-3 and transcriptional activation of Spp1. Knockdown of galectin-3 suppressed their ability to differentiate into OPN-producing cells, but not STAT3 activation. The tyrosine phosphorylation of STAT3 and the appearance rate of galectin-3hiCD206+ cells on cardiac CD11b+Ly6G- cells in Spp1 knockout mice were the same as those in wild-type mice. Spp1 knockout mice showed vulnerability to developing post-MI left ventricular chamber dilatation and the terminal deoxynucleo-tidyltransferase 2'-Deoxyuridine-5'-triphosphate nick-end labeling (TUNEL)-positive cells in the infarcted myocardium after MI remained higher in number in Spp1 knockout mice than in wild-type mice.
CONCLUSIONS: OPN is almost exclusively produced by galectin-3hiCD206+ macrophages, which specifically appear in the infarct myocardium after MI. The IL-10-STAT3-galectin-3 axis is essential for OPN-producing reparative macrophage polarization after myocardial infarction, and these macrophages contribute to tissue repair by promoting fibrosis and clearance of apoptotic cells. These results suggest that galectin-3 may contribute to reparative fibrosis in the infarct myocardium by controlling OPN levels.

Entities:  

Keywords:  galectin-3; myocardial infarction; osteopontin; wound healing

Mesh:

Substances:

Year:  2018        PMID: 29967195     DOI: 10.1161/CIRCULATIONAHA.118.035047

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  53 in total

Review 1.  Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.

Authors:  Nikolaos G Frangogiannis; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Can Macrophages in Cirrhotic Ascites Fluid Predict Clinical Outcome in Spontaneous Bacterial Peritonitis?

Authors:  Annie J Kruger
Journal:  Gastroenterology       Date:  2020-03-02       Impact factor: 22.682

3.  Human Embryonic Stem Cell-Derived Cardiovascular Progenitors Repair Infarcted Hearts Through Modulation of Macrophages via Activation of Signal Transducer and Activator of Transcription 6.

Authors:  Jinxi Wang; Meilan Liu; Qiang Wu; Qiang Li; Ling Gao; Yun Jiang; Boxiong Deng; Wei Huang; Wei Bi; Zhongyan Chen; Y Eugene Chin; Christian Paul; Yigang Wang; Huang-Tian Yang
Journal:  Antioxid Redox Signal       Date:  2019-04-16       Impact factor: 8.401

Review 4.  A New Era of Cardiac Cell Therapy: Opportunities and Challenges.

Authors:  Ke Huang; Shiqi Hu; Ke Cheng
Journal:  Adv Healthc Mater       Date:  2018-12-13       Impact factor: 9.933

Review 5.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 6.  Glucocorticoids and programming of the microenvironment in heart.

Authors:  Rui Song; Xiang-Qun Hu; Lubo Zhang
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

7.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

8.  Galectin-3 interferes with tissue repair and promotes cardiac dysfunction and comorbidities in a genetic heart failure model.

Authors:  Fani Vlachou; Aimilia Varela; Konstantina Stathopoulou; Konstantinos Ntatsoulis; Evgenia Synolaki; Harris Pratsinis; Dimitris Kletsas; Paschalis Sideras; Constantinos H Davos; Yassemi Capetanaki; Stelios Psarras
Journal:  Cell Mol Life Sci       Date:  2022-04-19       Impact factor: 9.261

9.  Basophils balance healing after myocardial infarction via IL-4/IL-13.

Authors:  Florian Sicklinger; Ingmar Sören Meyer; Xue Li; Daniel Radtke; Severin Dicks; Moritz P Kornadt; Christina Mertens; Julia K Meier; Kory J Lavine; Yunhang Zhang; Tim Christian Kuhn; Tobias Terzer; Jyoti Patel; Melanie Boerries; Gabriele Schramm; Norbert Frey; Hugo A Katus; David Voehringer; Florian Leuschner
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

10.  STAT3 but Not STAT5 Contributes to the Protective Effect of Electroacupuncture Against Myocardial Ischemia/Reperfusion Injury in Mice.

Authors:  Hui-Hui Guo; Xin-Yue Jing; Hui Chen; Hou-Xi Xu; Bing-Mei Zhu
Journal:  Front Med (Lausanne)       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.